Trillium Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-9,626	Closed	-$572K	–	238
2020 Q3	$572K	Sell	9,626 -4,397	-31%	-$300K	0.02%	186
2020 Q2	$978K	Sell	14,023 -295	-2%	-$18.7K	0.04%	174
2020 Q1	$650K	Sell	14,318 -40	-0.3%	-$2.27K	0.03%	180
2019 Q4	$934K	Sell	14,358 -792	-5%	-$52.9K	0.04%	185
2019 Q3	$941K	Buy	15,150 +154	+1%	+$9.67K	0.04%	188
2019 Q2	$1.07M	Buy	14,996 +1,779	+13%	+$131K	0.05%	179
2019 Q1	$1.04M	Buy	13,217 +6,186	+88%	+$469K	0.05%	180
2018 Q4	$595K	Buy	7,031 +274	+4%	+$29.2K	0.03%	191
2018 Q3	$1.16M	Sell	6,757 -248	-4%	-$37.4K	0.06%	183
2018 Q2	$905K	Sell	7,005 -39	-0.6%	-$4.35K	0.05%	186
2018 Q1	$726K	Sell	7,044 -269	-4%	-$26.6K	0.04%	189
2017 Q4	$625K	Sell	7,313 -13	-0.2%	-$1.13K	0.03%	186
2017 Q3	$622K	Buy	7,326 +95	+1%	+$7.52K	0.04%	184
2017 Q2	$548K	Buy	7,231 +324	+5%	+$22.7K	0.03%	188
2017 Q1	$456K	Buy	6,907 +609	+10%	+$40.1K	0.03%	186
2016 Q4	$399K	Buy	6,298 +561	+10%	+$35.4K	0.03%	189
2016 Q3	$365K	Buy	+5,737	New	+$421K	0.02%	189